FDA has released the transcript of the July 21 TPSAC meeting. CRE has reproduced the Tozzi presentation, attached hereto, and the Hennigfield criticism:
“The fact that the FDA and TPSAC continually, for whatever reason, refuse not to address the adverse impacts of counterfeit tobacco I think puts a cloud over this proceeding because, as in a point that I will make, there are a lot of proceedings around the world that address this particular issue.”
“Initially we were going to look solely at contraband but as we got into the record we saw very clearly that in our mind a huge and very important issue is the one associated with the health effects of these cigarettes”
“The statement that TPSAC has ignored the countervailing health effects of menthol ban is just frankly incredible.
“My conclusion is that to create these alarming conclusions, you frankly have to misrepresent some of the facts”
The Tozzi statement is very simple, TPSAC did not address the adverse health effects resulting from smoking counterfeit cigarettes.
Dr. Henningfield’s statement is an integral part of the TPSAC proceeding on menthol. Accordingly FDA must address the issue as to whether TPSAC examined the adverse health effects of counterfeit tobacco in its upcoming report.
CRE continues to examine the TPSAC report and we have found not one bit of information dealing with the adverse health effects of smoking counterfeit cigarettes.
If anyone has any information to the contrary please post it in the space provided below.